*001951205 *00520250613174206.0 *007ta *008020430s1999 xxu 000 u eng d *00900837cam a22002297c 4500 *019 $bl *035 $a(EXLNZ-47BIBSYS_NETWORK)990209916494702201 *035 $a(NO-LaBS)15046307(bibid) *035 $a(NO-TrBIB)020991649 *035 $a020991649-47bibsys_network *040 $aNO-TrBIB$bnob$ekatreg *24500$aPatient welfare and patient compliance :$ban empirical framework for measuring the benefits from pharmaceutical innovation *260 $aCambridge, Mass.$bNBER$c1999 *300 $a29 s. *4901 $aNBER working paper series$v6890 *7001 $aEllickson, Paul$_120074600 *7001 $aStern, Scott$_27477400 *7001 $aTrajtenberg, Manuel$_22554800 *7102 $aNational Bureau of Economic Research (Forente Stater)$_13074800 *830 0$aWorking paper series (National Bureau of Economic Research : trykt utg.)$x0898-2937$v6890$w999105437124702201$_13074900 *901 $a60 *999 $aoai:nb.bibsys.no:990209916494702202$b2021-11-14T21:09:39Z$z990209916494702202 ^